ATTRIBUTES INFLUENCING CHOICE OF ADJUVANT TREATMENT FOR MUSCLE-INVASIVE UROTHELIAL CANCER: QUALITATIVE RESEARCH

被引：0
|
作者：
Broughton, E. [1 ]
Steinberg, G. [2 ]
Harrison, M. [3 ]
Braverman, J. [4 ]
Alhasani, H. [4 ]
Beusterien, K. [5 ]
King-Concialdi, K. [5 ]
Wayser, G. [5 ]
机构：
[1] Bristol Myers Squibb, Lawrenceville, NJ USA
[2] New York Univ Langone Hlth, New York, NY USA
[3] Duke Canc Inst, Ctr Prostate & Urol Canc, Durham, NC USA
[4] Bristol Myers Squibb, Princeton, NJ USA
[5] Kantar Hlth, New York, NY USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN215
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma
    Mollica, Veronica
    Rizzo, Alessandro
    Massari, Francesco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 956 - 957
  • [2] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma
    Rizzo, Alessandro
    Mollica, Veronica
    Massari, Francesco
    [J]. LANCET ONCOLOGY, 2021, 22 (06): : E237 - E237
  • [3] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma
    Funada, Satoshi
    Luo, Yan
    [J]. LANCET ONCOLOGY, 2020, 22 (06): : E236 - E236
  • [4] Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder
    Alevizakos, Michail
    Bellmunt, Joaquim
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (03) : 259 - 267
  • [5] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma reply
    Bellmunt, Joaquim
    [J]. LANCET ONCOLOGY, 2021, 22 (06): : E238 - E238
  • [6] Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma REPLY
    Bajorin, Dean F.
    Collette, Sandra
    Galsky, Matthew D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 957 - 957
  • [7] Patient Preferences for Adjuvant Treatment in Muscle-Invasive Urothelial Carcinoma: A Multi-Country Discrete Choice Experiment
    King-Concialdi, Kristen
    Beusterien, Kathleen
    Senglaub, Steven S.
    Will, Oliver
    Jaffe, Dena H.
    Patel, Miraj Y.
    Harrison, Michael R.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2237 - 2248
  • [8] Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma
    Achkar, Tala
    Parikh, Rahul A.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) : 257 - +
  • [9] Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
    Bajorin, D. F.
    Witjes, J. A.
    Gschwend, J. E.
    Schenker, M.
    Valderrama, B. P.
    Tomita, Y.
    Bamias, A.
    Lebret, T.
    Shariat, S. F.
    Park, S. H.
    Ye, D.
    Agerbaek, M.
    Enting, D.
    McDermott, R.
    Gajate, P.
    Peer, A.
    Milowsky, M., I
    Nosov, A.
    Antonio Jr, J. N.
    Tupikowski, K.
    Toms, L.
    Fischer, B. S.
    Qureshi, A.
    Collette, S.
    Unsal-Kacmaz, K.
    Broughton, E.
    Zardavas, D.
    Koon, H. B.
    Galsky, M. D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (22): : 2102 - 2114
  • [10] Role of immunotherapy in perioperative treatment of localized muscle-invasive urothelial cancer
    Lewerich, J.
    Schmid, S. C.
    Gschwend, J. E.
    Retz, M.
    [J]. ONKOLOGIE, 2022, 28 (09): : 782 - 791
12345